Blockade of dopamine D2, but not of D1 receptors in the rat globus pallidus induced Fos-like immunoreactivity in the caudate-putamen, substantia nigra and entopeduncular nucleus

Neuroscience Letters

Volumn 271, Issue 2, 1999, Pages 73-76

  Hauber, Wolfgang ^a   Lutz, Sylke ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Caudate putamen; Entopeduncular nucleus; Fos like immunoreactivity; Rat; S( ) sulpiride; SCH23390; Substantia nigra

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; SULPIRIDE; DOPAMINE RECEPTOR BLOCKING AGENT; PROTEIN C FOS;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; CONTROLLED STUDY; ENTOPEDUNCULAR NUCLEUS; GLOBUS PALLIDUS; IMMUNOREACTIVITY; MALE; MOTOR CONTROL; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; SUBSTANTIA NIGRA; ANIMAL; BRAIN; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; SPRAGUE DAWLEY RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BRAIN; CAUDATE NUCLEUS; DOPAMINE ANTAGONISTS; GLOBUS PALLIDUS; MALE; PROTO-ONCOGENE PROTEINS C-FOS; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA;

EID: 0033587802     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00548-0     Document Type: Article

References (24)

1. Bevan M.D., Both P.A.C., Eaton S.A., Bolam J.P. Selective innervation of neostriatal interneurons by a subclass of neurons in the globus pallidus of the rat. J. Neurosci. 15:1998;9438-9452.
2. Celada P., Paladini C.A., Tepper J.M. GABAergic control of rats substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata. Neuroscience. 89:1999;813-825.
3. Chesselet M.F., Delfs J.M. Basal ganglia and movement disorders: an update. Trends Neurosci. 19:1996;417-422.
4. Costall B., Naylor R.J., Olley J.E. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. Neuropharmacology. 11:1972;645-663.
5. Dubois A., Savasta M., Curet O., Scatton B. Autoradiographic distribution of the D1 agonist [3H] SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors. Neuroscience. 19:1986;125-137.
6. Floran B., Aceves J., Sierra A., Martinez-Fong D. Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci. Lett. 116:1990;136-140.
7. Floran B., Floran L., Sierra A., Aceves J. D2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus. Neurosci Lett. 237:1997;1-4.
8. Hauber W., Hessel M., Lutz M. The role of pallidal dopamine D1- and D2-receptors in motor control of rats. Soc. Neurosci. Abstr. 23:1997;190.
9. Hauber W., Lutz S., Münkle M. The effects of globus pallidus-lesions on dopamine-dependent motor behaviour in rats. Neuroscience. 86:1998;147-157.
10. Kita H., Kitai S.T. The morphology of globus pallidus projection neurons in the rat - an intracellular staining study. Brain Res. 636:1994;308-319.
11. Limon I.D., Martinez-Fong M., Roslaes A., Nunez A., Aceves J. Dopamine inhibits GABA and stimulates glutamate release in the rat globus pallidus. Soc. Neurosci. Abstr. 23:1997;747.
12. Lindvall O., Björklund A. Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway. Brain Res. 172:1979;169-173.
13. Miwa H., Fuwa T., Nishi K., Mizuno Y. Effects of the globus pallidus lesion on the induction of c-Fos by dopaminergic drugs in the striatum possibly via pallidostriatal feedback loops. Neurosci. Lett. 240:1998;167-170.
14. Nambu A., Llinas R. Morphology of globus pallidus neurons: Its correlation with electrophysiology in guinea pig brain slices. J. Comp. Neurol. 377:1997;85-94.
15. Napier T.C., Simson P.E., Givens B.S. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus. J. Pharm. Exp. Ther. 258:1991;249-262.
16. Ossowska K., Karcz M., Wardas J., Wolfarth S. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy. Eur. J. Pharmacol. 182:1990;327-334.
17. Ossowska K., Smialowska M., Wolfarth S. A biphasic influence of globus pallidus lesions: spontaneous catalepsy followed by anticataleptic effect. Pharmacol. Biochem. Behav. 19:1983;169-176.
18. Ozer H., Ekinci A.C., Starr M.S. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata. Brain Res. 777:1997;51-59.
19. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
20. Robertson G.S., Robertson H.A. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J. Neurosci. 9:1989;3326.
21. Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science. 240:1988;1328-1331.
22. Scheel-Krüger J., Arnt J., Magelund G., Olianas M., Przewlocka B., Christensen A.V. Behavioural functions of GABA in basal ganglia and limbic systems. Brain Res. Bull. 5:1980;261-267.
23. Wirtshafter D. Fos expression in the basal ganglia following pharmacological inactivation of the globus pallidus. Soc. Neurosci. Abstr. 23:1997;467.
24. Yung K.K.L., Bolam J.P., Smith A.D., Hersch S.M., Ciliax B.J., Levey A.I. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience. 65:1995;709-730.